COST NO FEE

BOSTON MEDICAL CENTER CORPORATION - 75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183

PIID: 75N94023F00001
Signed Date: Nov 26, 2025Effective Date: Sep 28, 2023End Date: Closed on Feb 28, 2026
Award $
$126K
Vendor
BOSTON MEDICAL CENTER CORPORATION
NAICS
541714
Signed Date
Nov 26, 2025

Key Details

Dollars Obligated
$126,095
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
16
Place of Performance
BOSTON, MA, 021182908, CD-MA-07

Description

75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183

Context & Analysis

On Nov 26, 2025, Department of Health and Human Services obligated $126,095 to BOSTON MEDICAL CENTER CORPORATION for 75n94020d00004/75n94023f00001 - ovaprene vaginal device clinical trial - boston medical center - fy22 can 8054183. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 16 offers received. Performance is located in BOSTON, MA.

Contractor Information

UEI: JZ8RQC4EMDZ5
CAGE Code: 09PZ2
Location: BOSTON, MA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related